首頁 > 市場調查報告書 > 醫療設備

生技設備細胞培養

市場調查報告書

商品編碼

1588517

細胞培養市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Cell Culture Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月07日 | 出版商:

SkyQuest | 英文 208 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球細胞培養市場規模預計為282億美元，從2023年的320.1億美元成長到2031年的881.5億美元，預計在預測期內（2024-2031年）複合年成長率為13.50%。。

由於人們對其應用的認知不斷提高以及研究經費的雄厚，特別是在癌症研究方面，全球細胞培養市場正在經歷顯著成長。複雜的細胞培養技術的進步進一步增強了這種擴張。體外細胞培養涉及從組織中分離細胞並在排除植物和動物來源的受控環境中培養牠們。這種人工環境經過必需營養素的最佳化，並保持適當的 pH 值、濕度、氣體和溫度，以促進細胞生長和增殖。用於培養的細胞可以使用酵素或機械萃取方法生長，使研究人員能夠使用已建立的細胞株和菌株進行實驗。該過程依賴各種設備和消耗品，包括重要的化學物質來建立生長條件。受控的物理化學環境、各種生長因子、荷爾蒙、氣體、基材和培養基等關鍵組件對於高效的細胞培養操作至關重要。總體而言，在技術進步和對生命科學領域研發的日益關注的推動下，該市場呈現出充滿希望的趨勢。

市場概況
消耗品
- 血清、培養基、試劑
- 媒體
- 無血清培養基
- 經典介質和鹽
- 幹細胞培養基
- 化學成分確定的培養基
- 專門的培養基
- 其他媒體
- 試劑
- 生長因子
- 補充品
- 緩衝液和化學品
- 細胞分離試劑
- 平衡鹽溶液
- 依戀因素和基質因素
- 抗生素/抗真菌藥
- 防凍試劑
- 污染檢測套件
- 其他試劑
- 獅子山
- 牛
- 牛血清
- 其他動物血清
- 船
- 電池工廠系統/電池堆
- 滾筒/婁瓶
- 燒瓶
- 多孔孔盤
- 培養皿
- 配件
裝置
- 反應器
- 常規反應器
- 反應器
- 儲存設備
- 冰箱/冷凍庫
- 冷凍系統
- 其他設備
- 過濾系統
- 細胞計數器
- 二氧化碳培養箱
- 離心機
- 高壓釜
- 顯微鏡
- 生物安全櫃
- 其他輔助設備

細胞培養市場：依應用分類

市場概況
生物製藥製造
- 單株抗體生產
- 疫苗生產
- 其他治療性蛋白質的生產
診斷
組織工程與再生醫學
- 細胞/基因治療
- 其他組織工程及再生醫學應用
藥物篩檢與開發
其他用途

細胞培養市場：依最終用戶分類

市場概況
製藥和生物技術公司
醫院和診斷實驗室
研究/學術機構
其他最終用戶

細胞培養市場：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Danaher Corporation（US）
Merck KGAA（Germany）
Sartorius AG（Germany）
Corning Incorporated（US）
Fujifilm Holdings Corporation（Japan）
BD（Becton, Dickinson and Company）（US）
Eppendorf SE（Germany）
Lonza（Switzerland）
Getinge AB（Sweden）
Agilent Technologies, Inc.（US）
Himedia Laboratories（India）
Bio-Techne（US）
Miltenyi Biotec（Germany）
Stemcell Technologies（Canada）
Solida Biotech GmbH（Germany）
Caisson Labs Inc.（US）
Promocell GmbH（Germany）
Invivogen（US）
Pan-Biotech（Germany）
Cellexus（UK）
Meissner Filtration Products, Inc.（US）
Adolf Kuhner AG（Switzerland）
Advancion Corporation（US）
Biospherix, Ltd.（US）

簡介目錄

Product Code: SQMIG35H2257

Global Cell Culture Market size was valued at USD 28.2 billion in 2022 and is poised to grow from USD 32.01 billion in 2023 to USD 88.15 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The global cell culture market is witnessing significant growth driven by increased awareness regarding its applications and robust funding for research, particularly in cancer studies. This expansion is further bolstered by advancements in sophisticated cell culture technologies. In vitro cell culture involves isolating cells from tissues and nurturing them in a controlled environment devoid of plant or animal sources. This artificial setup is optimized with essential nutrients, maintaining appropriate pH levels, humidity, gases, and temperature to facilitate cell growth and proliferation. Cells for culture can be sourced through enzyme-based or mechanical extraction methods, and researchers can utilize established cell lines or strains for their experiments. The process relies on various instruments and consumables, including chemicals that are critical for establishing the growth conditions. Essential components such as a controlled physico-chemical environment, along with various growth factors, hormones, gases, substrates, and media, are vital for efficient cell culture operations. Overall, the market demonstrates promising trends fueled by technological evolution and a growing emphasis on research development within the life sciences field.

Top-down and bottom-up approaches were used to estimate and validate the size of the global cell culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global cell culture Market Segmental Analysis

Global Cell Culture Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Equipment. Based on Application, the market is segmented into Biopharmaceutical Production, Diagnostics, Tissue Engineering & Regenerative Medicine, Drug Screening & Development, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global cell culture Market

The surge in demand for biopharmaceuticals, particularly cell-based therapies and monoclonal antibodies, is a significant market driver for the global cell culture market. This trend is largely influenced by the rising prevalence of chronic diseases, including diabetes, cancer, and autoimmune disorders, which require advanced therapeutic solutions. As a result, the pharmaceutical industry increasingly relies on sophisticated cell culture techniques for large-scale production, research, and development of these biologics. This growing need for effective treatment options not only propels innovation in cell culture technologies but also expands the market, fostering investments and advancements in the sector to meet regulatory and production demands.

Restraints in the global cell culture Market

The global cell culture market faces significant restraints due to ethical concerns surrounding the use of stem cells and animal-derived components in research and product development. These ethical dilemmas are particularly pronounced in regions with stringent regulatory frameworks, where compliance can become an onerous process that stifles innovation. The necessity to navigate complex regulations not only complicates the approval of cell-based products but also hinders the entry of new players into the market. As a result, these challenges can limit the overall growth potential of the cell culture market, leading to reduced investment and slower advancements in biotechnological applications.

Market Trends of the global cell culture Market

The global cell culture market is experiencing a significant shift towards 3D cell culture systems, reflecting a growing preference for models that more accurately mimic in vivo conditions compared to traditional 2D systems. This trend is revolutionizing drug discovery, cancer research, and toxicity testing by enhancing the physiological relevance of experimental results. As stakeholders seek improved efficacy in therapeutic development and better human tissue modeling, the adoption of 3D technologies is projected to accelerate. With advancing biotechnologies and increasing investments in research and development, the market is poised for robust growth, solidifying 3D cell culture as a critical component in biomedical research and pharmaceutical innovation.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Technology Analysis
Patent Analysis
Value Chain Analysis
Supply Chain Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Cell Culture Market by Product

Market Overview
Consumables
- Sera, Media, and Reagents
- Media
- Serum-Free Media
- Classical Media & Salts
- Stem Cell Culture Media
- Chemically Defined Media
- Specialty Media
- Other Media
- Reagents
- Growth Factors
- Supplements
- Buffers & Chemicals
- Cell Dissociation Reagents
- Balanced Salt Solutions
- Attachment & Matrix Factors
- Antibiotics/Antimycotics
- Cryoprotective Reagents
- Contamination Detection Kits
- Other Reagents
- Sera
- Fetal Bovine Sera
- Adult Bovine Sera
- Other Animal Sera
- Vessels
- Cell Factory Systems/Cell Stacks
- Roller/Roux Bottles
- Flasks
- Multiwell Plates
- Petri Dishes
- Accessories
Equipment
- Bioreactors
- Conventional Bioreactors
- Single-Use Bioreactors
- Storage Equipment
- Refrigerators & Freezers
- Cryostorage Systems
- Other Equipment
- Filtration Systems
- Cell Counters
- Carbon Dioxide Incubators
- Centrifuges
- Autoclaves
- Microscopes
- Biosafety Cabinets
- Other Supporting Equipment

Cell Culture Market by Application

Market Overview
Biopharmaceutical Production
- Monoclonal Antibody Production
- Vaccine Production
- Other Therapeutic Protein Production
Diagnostics
Tissue Engineering & Regenerative Medicine
- Cell & Gene Therapy
- Other Tissue Engineering & Regenerative Medicine Applications
Drug Screening & Development
Other Applications

Cell Culture Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Other End Users

Cell Culture Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solida Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caisson Labs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promocell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invivogen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pan-Biotech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellexus (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meissner Filtration Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adolf Kuhner AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advancion Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biospherix, Ltd. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments